Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$680M |
| 2 |
Microsoft
MSFT
|
+$506M |
| 3 |
UnitedHealth
UNH
|
+$393M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$381M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$348M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.24B |
| 2 |
Tesla
TSLA
|
+$450M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$444M |
| 4 |
TSMC
TSM
|
+$432M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$371M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.79% |
| 2 | Consumer Discretionary | 0.82% |
| 3 | Financials | 0.79% |
| 4 | Healthcare | 0.66% |
| 5 | Industrials | 0.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
CALL
Ball Corp
BALL
$17B
| $16.6M | ﹤0.01% |
296,500
+116,600
| +65% | +$6.09M |
|
2202
PUT
Sprott Uranium Miners ETF
URNM
$2.26B
| $16.6M | ﹤0.01% |
346,900
-145,800
| -30% | -$5.53M |
|
2203
CALL
Jazz Pharmaceuticals
JAZZ
$16.2B
| $16.6M | ﹤0.01% |
156,600
+46,400
| +42% | +$5.04M |
|
2204
Ocular Therapeutix
OCUL
$2.37B
| $16.6M | ﹤0.01% |
1,788,603
+1,349,159
| +307% | +$10.6M |
|
2205
Burlington
BURL
$19.8B
| $16.6M | ﹤0.01% |
71,347
-1,141
| -2% | -$271K |
|
2206
PUT
Ciena
CIEN
$57.2B
| $16.6M | ﹤0.01% |
203,800
-63,100
| -24% | -$4.53M |
|
2207
PUT
Omega Healthcare
OHI
$14.2B
| $16.6M | ﹤0.01% |
452,200
+298,000
| +193% | +$11.1M |
|
2208
Avis
CAR
$5.09B
| $16.6M | ﹤0.01% |
97,968
+59,420
| +154% | +$6.4M |
|
2209
CALL
Zions Bancorporation
ZION
$9.97B
| $16.6M | ﹤0.01% |
318,800
+15,700
| +5% | +$737K |
|
2210
PUT
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
| $16.6M | ﹤0.01% |
178,700
+60,700
| +51% | +$5.46M |
|
2211
PUT
M&T Bank
MTB
$34.9B
| $16.5M | ﹤0.01% |
85,300
+700
| +0.8% | +$124K |
|
2212
PUT
Nektar Therapeutics
NKTR
$2.52B
| $16.5M | ﹤0.01% |
640,300
+638,467
| +34,832% | +$7.17M |
|
2213
Uranium Energy
UEC
$6.5B
| $16.5M | ﹤0.01% |
2,429,384
+1,716,022
| +241% | +$9.62M |
|
2214
SentinelOne
S
$7.03B
| $16.5M | ﹤0.01% |
902,979
+466,330
| +107% | +$8.53M |
|
2215
CALL
Watsco Inc
WSO
$13B
| $16.5M | ﹤0.01% |
37,300
+3,500
| +10% | +$1.62M |
|
2216
PUT
Maplebear
CART
$11.8B
| $16.5M | ﹤0.01% |
364,000
-69,200
| -16% | -$3.01M |
|
2217
Veracyte
VCYT
$3.56B
| $16.5M | ﹤0.01% |
608,845
+72,441
| +14% | +$2.1M |
|
|
ESGR
2218
CALL
DELISTED
Enstar Group
ESGR
| $16.4M | ﹤0.01% |
48,900
+1,500
| +3% | +$502K |
|
2219
CALL
Franklin Templeton
BEN
$17.8B
| $16.4M | ﹤0.01% |
688,700
+4,500
| +0.7% | +$92.7K |
|
2220
Wingstop
WING
$3.06B
| $16.4M | ﹤0.01% |
48,776
-7,347
| -13% | -$2.17M |
|
2221
PUT
BioMarin Pharmaceuticals
BMRN
$12.7B
| $16.4M | ﹤0.01% |
298,700
-6,300
| -2% | -$371K |
|
2222
PUT
Krystal Biotech
KRYS
$10.6B
| $16.4M | ﹤0.01% |
119,400
+91,600
| +329% | +$13.5M |
|
2223
Bunge Global
BG
$21.8B
| $16.4M | ﹤0.01% |
204,208
-24,206
| -11% | -$1.91M |
|
2224
PUT
iShares US Broker-Dealers & Securities Exchanges ETF
IAI
$1.41B
| $16.4M | ﹤0.01% |
96,900
+200
| +0.2% | +$29.5K |
|
2225
PUT
Verisk Analytics
VRSK
$24.5B
| $16.4M | ﹤0.01% |
52,600
+21,100
| +67% | +$6.4M |
|
Similar funds
Jeff Yass's Q2 2025 Portfolio in Review
As of Q2 2025, Jeff Yass held 14,080 positions worth $720B, up 23% from $586B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jeff Yass's Q2 2025 filing shows 1,720 new, 5,716 increased, 5,055 reduced and 1,538 closed positions. Its largest new stake was iShares Core MSCI Total International Stock ETF: 1,549,778 shares worth $120M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.24B.
By sector, the portfolio is most concentrated in Technology at 1.8% of assets, up from 1.6% a quarter earlier, followed by Consumer Discretionary and Financials.
- Jeff Yass's largest Q2 2025 buy was iShares Core MSCI Total International Stock ETF: 1,549,778 shares worth $120M.
- Jeff Yass added most to Apple in Q2 2025, an estimated $680M increase.
- Jeff Yass's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.24B.
- Jeff Yass fully exited Vanguard Intermediate-Term Bond ETF in Q2 2025, selling an estimated $61.8M.
- Jeff Yass's ten largest holdings make up 26% of its $720B portfolio in Q2 2025.
- Jeff Yass opened 1,720 new positions and closed 1,538 in Q2 2025.
- Jeff Yass's portfolio value rose 23% quarter-over-quarter to $720B.
Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.